{site_meta && site_meta.display_name} Logo

NewMediaWire

NewMediaWire distributes press releases on behalf of hundreds of publicly traded companies, as well as private corporations, non-profits and other public sector organizations. Founded and staffed by industry veterans, we offer a full complement of services including specialized delivery to financial sites and posting of photos and multimedia content. In addition, NewMediawire offers international and specialized services such as IR websites and industry specific distribution.

RSS Feed for NewMediaWire

EzaLife StartEngine Campaign Closing April 6

April 7, 2026COLUMBUS, OH - April 6, 2026 (NEWMEDIAWIRE) - Ezalife has entered the final days of its equity crowdfunding campaign on StartEngine, with the raise set to close on April 6. The company, which developed the FDA-registered Button Huggie® device, is addressing a critical issue impacting over 1 million families annually who rely on feeding tubes.


Avolta Publishes Invitation to Its Annual General Meeting 2026

April 6, 2026BASEL, SWITZERLAND - April 6, 2026 (NEWMEDIAWIRE) - Avolta today published the invitation to its Annual General Meeting 2026. The event will take place on May 06, 2026 at 14:30 CEST, at Rhypark, Muhlhauserstrasse 17, 4056 Basel, Switzerland.


Heidelberg Pharma to Present Data From Its ADC Technology Platform at AACR Annual Meeting 2026

April 6, 2026LADENBURG, GERMANY - April 6, 2026 (NEWMEDIAWIRE) - Heidelberg Pharma AG (FSE: HPHA), a clinical-stage biotech company developing innovative Antibody Drug Conjugates (ADCs), will present promising preclinical data from its Amanitin-based ADC HDP-103 targeting metastatic castration‑resistant prostate cancer (mCRPC) at the American Association of Cancer Research (AACR) Annual Meeting 2026 in San Diego, California, USA, from 17 to 22 April. AACR Annual Meeting 2026 Details of the conference and poster presentation are as follow: Poster: HDP-103, a PSMA targeting amanitin-based ADC, is efficacious even in difficult to treat patient derived xenograft models with heterogenous PSMA expressionPoster number: 5639Session: Antibody-Drug Conjugates and Linker Engineering 4Presentation time: 21 April, 2:00 pm – 5:00 pm PDTLink to abstract: https://www.


A2Z Cust2Mate Solutions (AZ) Secures $50M Smart Cart Deal With Carrefour Israel

April 6, 2026LOS ANGELES, CA - April 6, 2026 (NEWMEDIAWIRE) - A2Z Cust2Mate Solutions Corp. (NASDAQ: AZ) announced a five-year strategic agreement valued at approximately $50 million with Carrefour Israel to deploy 4,000 smart carts across its store network, alongside a broader collaboration spanning data, retail media and digital services.


Focus Universal Inc. Announces $4.0 Million Private Placement Priced at the Market Under Nasdaq Rules

April 6, 2026WEST COVINA, CA - April 6, 2026 (NEWMEDIAWIRE) - Focus Universal Inc. (NASDAQ: FCUV) (the “Company”), a provider of patented hardware and software design technologies for the Internet of Things (IoT), 5G, and AI-driven SEC financial reporting automation software, today announced that it has entered into definitive agreements with institutional investors for the purchase and sale of approximately $4.


Datavault AI (DVLT) to Showcase RWA Tokenization Technologies at XRP Tokyo 2026

April 6, 2026LOS ANGELES, CA - April 6, 2026 (NEWMEDIAWIRE) - Datavault AI (NASDAQ: DVLT) announced that CEO Nathaniel T. Bradley will present and exhibit the Company’s DataValue(R), DataScore(R), Data Vault Bank(R) AI Agent and Information Data Exchange(R) technologies at XRP Tokyo 2026 on April 7, 2026, highlighting its AI-powered infrastructure for real-world asset tokenization as it targets Japan’s rapidly expanding, regulation-friendly market and broader APAC growth opportunities.


ADM Endeavors (ADMQ) Announces Operational Consolidation Into New Corporate Headquarters and Expects Significant Reduction in Facility Expenses

April 6, 2026FORT WORTH, TX - April 6, 2026 (NEWMEDIAWIRE) - ADM Endeavors, Inc. (OTCQB: ADMQ), a vertically integrated provider of custom apparel, uniforms, promotional products, screen printing, embroidery, digital production, and fulfillment services, today announced the ongoing consolidation of operations into the Company’s new corporate headquarters and production facility in Fort Worth, Texas.


HKTDC's Response to World Trade Organization's Latest Report

April 3, 2026HONG KONG - April 3, 2026 (NEWMEDIAWIRE) - The World Trade Organization’s latest Global Trade Outlook and Statistics report shows that Hong Kong rose to become the world’s fifth-largest trading entity in 2025, climbing two places from the preceding year. The Hong Kong Trade Development Council (HKTDC) noted that the WTO report fully demonstrated Hong Kong’s continued resilience in merchandise trade.


OMRON Healthcare and UCSF Launch AFib Trial

April 3, 2026Study Will Explore Early Detection of Atrial Fibrillation to Reduce Stroke and Heart Failure Risk Through Home Blood Pressure Monitoring KYOTO, JAPAN - April 3, 2026 (NEWMEDIAWIRE) - OMRON Healthcare Co. , Ltd.


Tim Draper to Keynote Investment Crowdfunding Week

April 3, 2026Tim Draper to Keynote Investment Crowdfunding Week 2026 as Private Market Access Reaches an Inflection Point Second annual investment crowdfunding conference features one of venture's most recognizable voices BINGHAMTON, NY - April 2, 2026 (NEWMEDIAWIRE) - Kingscrowd announced Tim Draper will deliver the keynote address opening Investment Crowdfunding Week 2026 on April 13. The billionaire venture capitalist behind early bets on Skype, Tesla, Baidu, and Bitcoin has spent his career getting ahead of structural shifts in how capital moves.


TibaRay Launches Wefunder Campaign to Advance FLASH Radiotherapy Technology

April 3, 2026FREMONT, CA - April 2, 2026 (NEWMEDIAWIRE) - TibaRay has launched its Regulation CF campaign on Wefunder, opening the company to individual investors as it continues developing next generation accelerator technology designed to enable FLASH radiotherapy. TibaRay’s mission is to cure cancer in a FLASH by enabling radiation to be delivered hundreds of times faster than current systems.


Ezalife Clinical Results Show 77% Reduction in Feeding Tube Dislodgement

April 3, 2026COLUMBUS, OH - April 2, 2026 (NEWMEDIAWIRE) - Ezalife announced compelling clinical results demonstrating that its Button Huggie® device achieved a 77% reduction in feeding tube dislodgement, addressing a long-standing challenge in patient care. Feeding tubes, commonly secured with tape and gauze, have remained largely unchanged for decades, often leading to discomfort, complications, and emergency interventions.


North Capital Trust Company Receives South Dakota Public Trust Company Charter

April 3, 2026SALT LAKE CITY, UT - April 2, 2026 (NEWMEDIAWIRE) - North Capital Investment Technology, Inc. , a financial technology company providing technology solutions to private securities issuers, intermediaries, and investors, today announced that its wholly owned subsidiary, North Capital Trust Company, has received from the South Dakota Division of Banking a Charter and Certificate of Authority to transact business as a Public Trust Company.


flatexDEGIRO Extends CEO Oliver Behrens' Board Mandate Early

April 2, 2026 The term of office of Oliver Behrens as CEO of flatexDEGIRO has been extended early until 31 March 2029 Focus on continuity and stability in the Company’s leadership FRANKFURT AM MAIN, GERMANY - April 2, 2026 (NEWMEDIAWIRE) - The Supervisory Board of flatexDEGIRO SE today resolved to reappoint Oliver Behrens as Chief Executive Officer (CEO) of the Company. His original term of office, which was due to expire on 30 September 2027, has been extended early until 31 March 2029 by way of reappointment.


NeuroOne® Medical Technologies Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

April 2, 2026EDEN PRAIRIE, MINN. - April 2, 2026 (NEWMEDIAWIRE) - NeuroOne Medical Technologies Corporation (Nasdaq: NMTC), a medical technology company dedicated to transforming the surgical diagnosis and treatment of neurological disorders, today announced that, effective April 1, 2026, its independent directors approved an equity award under NeuroOne’s 2021 Inducement Plan, as a material inducement to an individual entering into employment with the Company.